(Q43080330)

13 November 2017

title

Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies (English)

1 reference

systemic lupus erythematosus

13 November 2017

1 reference

1 reference

R Ben Mansour

1

1 reference

13 November 2017

S Lassoued

2

1 reference

13 November 2017

A Elgaied

3

1 reference

13 November 2017

S Haddouk

4

1 reference

13 November 2017

S Marzouk

5

1 reference

13 November 2017

Z Bahloul

6

1 reference

13 November 2017

H Masmoudi

7

1 reference

13 November 2017

H Attia

8

1 reference

13 November 2017

M S Aïfa

9

1 reference

13 November 2017

F Fakhfakh

10

1 reference

13 November 2017

publication date

1 May 2010

1 reference

Scandinavian Journal of Rheumatology

13 November 2017

published in

1 reference

13 November 2017

volume

39

1 reference

13 November 2017

issue

3

1 reference

13 November 2017

page(s)

247-253

1 reference

Pathogenesis and spectrum of autoimmunity

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxygen free radicals and systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Recognition of oxidized DNA bases by sera of patients with inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

The role of nitric oxide in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Free radicals and antioxidants in normal physiological functions and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Quantification and significance of protein oxidation in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Role of reactive aldehyde in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Free radical mediated peroxidative damage in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Autoimmunity and oxidatively modified autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidative damage to plasma proteins in adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Decreased sulfhydryl groups of serum albumin in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidatively modified autoantigens in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

New target antigens for anti-endothelial cell antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

Protein-bound 4-Hydroxy-2-nonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903362511

10.3109/03009740903362511

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference